Diwa, Khalif M.

HRN: 27-84-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/30/2025
01/06/2026
IV DRIP
480mg
Q8
PCAP-C With Moderate Dehydration
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines